| Literature DB >> 29935771 |
Arthur F Kluge1, Bharat R Lagu2, Pranab Maiti3, Mahaboobi Jaleel3, Michael Webb1, Jyoti Malhotra1, Ashley Mallat1, P Akhila Srinivas3, James E Thompson1.
Abstract
Mitophagy is one of the processes that cells use to maintain overall health. An E3 ligase, parkin, ubiquitinates mitochondrial proteins prior to their degradation by autophagasomes. USP30 is an enzyme that de-ubiquitinates mitochondrial proteins; therefore, inhibiting this enzyme could foster mitophagy. Herein, we disclose the structure-activity relationships (SAR) within a novel series of highly selective USP30 inhibitors. Two structurally similar compounds, MF-094 (a potent and selective USP30 inhibitor) and MF-095 (a significantly less potent USP30 inhibitor), serve as useful controls for biological evaluation. We show that MF-094 increases protein ubiquitination and accelerates mitophagy.Entities:
Keywords: Deubiquitinase inhibitor; Mitophagy; Parkin; USP30
Mesh:
Substances:
Year: 2018 PMID: 29935771 DOI: 10.1016/j.bmcl.2018.05.013
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823